FTC finds middlemen inflate specialty generic drug prices by billions of dollars
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs between 2017 and 2022,
Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says
The largest pharmacy-benefit managers hiked the prices of certain drugs dispensed through their own pharmacies, according to a new report by the Federal Trade Commission released on Tuesday. The markups helped the PBMs reap $7.
US FTC Finds Major Pharmacy Benefit Managers Inflated Drug Prices for $7.3 Billion Gain
UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts -- marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue in excess of the acquisition costs of the drugs,
Major PBMs Inflated Drug Prices, Pocketing $7.3 Billion Along the Way, FTC Says
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of acquisition, earning more than $7.3 billion in revenue from 2017 to 2022, according to a report issued by the Federal Trade Commission (FTC) on Tuesday.
FTC says pharmacy benefits managers marked-up generic drug prices for $7.3bn gain
Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments
Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
Will ‘click to cancel’ get canceled? New FTC rule faces legal, political challenges
It takes effect Tuesday but its fate is already in doubt. The new FTC rule faces legal challenges and possible opposition ...
Apartment giant Greystar facing FTC lawsuit over misleading rental fees
The suit accuses the company of falsely advertising rental prices by failing to inform renters of numerous mandatory fees.
PBMs made billions marking up speciality drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
Federal Trade Commission accuses Greystar of deceptive practices, hidden fees
The antitrust agency recently created a rule regarding junk fees, but its application to the multifamily sector is unclear.
Accounting Today13h
FTC mandates changes at H&R Block
A Federal Trade Commission order requires the tax prep giant to make it easier for customers to use cheaper options.
Healthcare Dive12h
FTC releases second report slamming pharmacy benefit managers
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
JD Supra9h
FTC Announces 2025 Thresholds for Hart-Scott-Rodino Premerger Filings and Fees
On Jan. 10, 2025, the Federal Trade Commission (FTC) announced its annual adjustments to the premerger filing thresholds under the ...
STAT10h
FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system
For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.
Federal Trade Commission sets closed door meeting for next Thursday
The Federal Trade Commission has scheduled a closed-door meeting for next Thursday as FTC Chair Lina Khan's reign nears an ...
JD Supra11h
FTC Announces 2025 Revised HSR Thresholds and Filing Fees
On January 10, 2025, the Federal Trade Commission (FTC) announced its annual adjustments to the filing thresholds and fees under the ...